YM-60828, a novel factor Xa inhibitor: Separation of its antithrombotic effects from its prolongation of bleeding time

Author： Sato K. Kawasaki T. Taniuchi Y. Hirayama F. Koshio H. Matsumoto Y.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.339, Iss.2, 1997-11, pp. : 141-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antithrombotic effect of YM-75466 is separated from its effect on bleeding time and coagulation time

By Sato K. Kaku S. Hirayama F. Koshio H. Matsumoto Y. Kawasaki T. Iizumi Y.

European Journal of Pharmacology, Vol. 352, Iss. 1, 1998-07 ,pp. : 59-63

Elsevier

Access to resources Recommend Favorite

Relationship between the antithrombotic effect of YM-75466, a novel factor Xa inhibitor, and coagulation parameters in rats

By Sato K. Taniuchi Y. Kawasaki T. Hirayama F. Koshio H. Matsumoto Y.

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite

Antithrombotic effects of YM-60828 in three thrombosis models in guinea pigs

By Sato K. Kawasaki T. Hisamichi N. Taniuchi Y. Hirayama F. Koshio H. Ichihara M. Matsumoto Y.

European Journal of Pharmacology, Vol. 350, Iss. 1, 1998-05 ,pp. : 87-91

Elsevier

Access to resources Recommend Favorite

Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy

By Turpie Alexander GG

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1373-1384

Informa Healthcare

Access to resources Recommend Favorite

Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis

By Heran C. Morgan S. Kasiewski C. Bostwick J. Bentley R. Klein S. Chu V. Brown K. Colussi D. Czekaj M. Perrone M. Leadley R.

European Journal of Pharmacology, Vol. 389, Iss. 2, 2000-02 ,pp. : 201-207

Elsevier

Access to resources Recommend Favorite